![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 21, 2020 3:30:39 PM
https://www.proactiveinvestors.com/companies/news/916520/nanoviricides-continuing-their-work-to-find-a-treatment-for-covid-19-916520.html
Couple of notes:
(1) claims can make kg scale batches, which would provide what sounded like 500,000 doses per batch
(2) claims one nanoviricide can neutralize / "slime" one coronavirus particle
(3) says is very, very confident they can come up with something within a few weeks
(4) repeats that viral assays were up and running quickly - in around 3 weeks. Poor Dr. Friedrich looked like a bored prop. I think he was probably relegated to consultant status to save $, and was recently brought back in as an "employee" for this project. Dr. Jayant Tatanke (sp?) also looked like a prop. As did the outfits. What likely wasn't a prop was the unshaven Diwan, who may? be working hard to find a cure for COVID-19.
(5) claims that have already been in discussion with big-pharma to fund and collaborate with ACE2bCoV-Cide development.
Anyways, wonder what the huge volume SP spike is about today? Would guess they may be announcing success against other less virulent species of betacoronavirus that use similar spike protein to bind to ACE2 to enter cells as used by SARS2 bCoV.
Yeah, someone knows something, and it's not anybody here, who provide all the usual repetitive commentary.
Will see what they have to say tomorrow. Hopefully will note progress on IND.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM